Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | -2.67% | -13.33% | +43.31% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.11M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.05
x | P/E ratio 2025 * |
-1.39
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.15% |
Latest transcript on Inhibikase Therapeutics, Inc.
1 day | -2.14% | ||
1 week | -13.33% | ||
Current month | -15.74% | ||
1 month | -17.65% | ||
3 months | -26.02% | ||
6 months | +121.63% | ||
Current year | +43.31% |
Managers | Title | Age | Since |
---|---|---|---|
Milton Werner
FOU | Founder | 61 | 08-08-31 |
C. Warren Olanow
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Surendra Singh
COO | Chief Operating Officer | - | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Berman
BRD | Director/Board Member | 73 | 19-08-31 |
Paul Grint
BRD | Director/Board Member | 66 | 20-12-21 |
Milton Werner
FOU | Founder | 61 | 08-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.82 | -2.67% | 14 627 |
24-04-24 | 1.87 | +18.35% | 62,249 |
24-04-23 | 1.58 | +15.33% | 79,090 |
24-04-22 | 1.37 | -32.84% | 369,205 |
24-04-19 | 2.04 | -2.86% | 52,727 |
Delayed Quote Nasdaq, April 25, 2024 at 12:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.31% | 12.11M | |
+0.73% | 43.84B | |
+5.52% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.21% | 25.53B | |
-25.11% | 18.18B | |
-3.42% | 12.29B | |
+26.52% | 12.29B | |
+6.63% | 11.15B |
- Stock Market
- Equities
- IKT Stock